BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18486169)

  • 1. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe.
    Midzi N; Sangweme D; Zinyowera S; Mapingure MP; Brouwer KC; Kumar N; Mutapi F; Woelk G; Mduluza T
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):759-66. PubMed ID: 18486169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
    Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
    PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
    Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
    Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
    Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.
    Zinyama-Gutsire R; Gomo E; Kallestrup P; Erikstrup C; Ullum H; Butterworth AE; Munyati S; Mduluza T
    BMC Infect Dis; 2009 Oct; 9():174. PubMed ID: 19852800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
    Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of single-dose 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: An individual participant data meta-analysis.
    Olliaro PL; Coulibaly JT; Garba A; Halleux C; Keiser J; King CH; Mutapi F; N'Goran EK; Raso G; Scherrer AU; Sousa-Figueiredo JC; Stete K; Utzinger J; Vaillant MT
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008277. PubMed ID: 32569275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community.
    Adewale B; Mafe MA; Sulyman MA; Idowu ET; Ajayi MB; Akande DO; Mckerrow JH; Balogun EO
    Korean J Parasitol; 2018 Dec; 56(6):577-581. PubMed ID: 30630278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
    Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK
    Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial.
    Coulibaly JT; Panic G; Yapi RB; Kovač J; Barda B; N'Gbesso YK; Hattendorf J; Keiser J
    BMC Med; 2018 Jun; 16(1):81. PubMed ID: 29855373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
    Mutapi F; Rujeni N; Bourke C; Mitchell K; Appleby L; Nausch N; Midzi N; Mduluza T
    PLoS Negl Trop Dis; 2011 May; 5(5):e1143. PubMed ID: 21610855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children.
    Stete K; Krauth SJ; Coulibaly JT; Knopp S; Hattendorf J; Müller I; Lohourignon LK; Kern WV; N'goran EK; Utzinger J
    Parasit Vectors; 2012 Dec; 5():298. PubMed ID: 23259435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
    Barda B; Coulibaly JT; Hatz C; Keiser J
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005400. PubMed ID: 28222149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire.
    N'Goran EK; Gnaka HN; Tanner M; Utzinger J
    Ann Trop Med Parasitol; 2003 Jan; 97(1):37-51. PubMed ID: 12662421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
    Taylor P; Murare HM; Manomano K
    J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of praziquantel efficacy at 40 mg/kg and 60 mg/kg in treating Schistosoma haematobium infection among schoolchildren in the Ingwavuma area, KwaZulu-Natal, South Africa.
    Kabuyaya M; Chimbari MJ; Mukaratirwa S
    S Afr Med J; 2020 Jul; 110(7):657-660. PubMed ID: 32880343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.